Sean Ellis - 18 Jan 2022 Form 4/A - Amendment Insider Report for Entera Bio Ltd. (ENTX)

Role
Director
Signature
/s/ Dana Yaacov-Garbeli, Attorney-in-fact
Issuer symbol
ENTX
Transactions as of
18 Jan 2022
Net transactions value
$0
Form type
4/A - Amendment
Filing time
25 Jul 2022, 17:21:58 UTC
Date Of Original Report
19 Jan 2022
Previous filing
14 Jan 2022
Next filing
25 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ENTX Ordinary Shares, par value NIS 0.0000769 per share 17,200 18 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 amendment is being filed to correct the original Form 4 filed on January 19, 2022. The original Form 4 inadvertently omitted 7,200 ordinary shares held directly by the Reporting Person.